Canada approves use of AstraZeneca Covid-19 vaccine
Ottawa, Feb 27 Canada announced its approval of the use of the Covid-19 vaccine co-developed by the University ...
Vaccine against new Covid variants may take 6-9 months: AstraZeneca
London, Feb 11 Pharmaceutical company AstraZeneca said it could take between six to nine months to produce Covid-19 ...
Gene editing techniques helpful in retinal degeneration treatment
A new study has found that gene-editing techniques like CRISPR-Cas hold the power to rectify inherited retinal degenerative mutations, which are the primary cause of blindness.
Study highlights genome altering can help to treat human retinal degeneration
A study published in journal Human Gene Therapy shows that gene editing therapies, including CRISPR-Cas frameworks, offer the possibility to address transformations causing inherited retinal degenerations, a leading cause of blindness.
Delhi-based student lands research internship offer from over 10 world-famous universities
Achieving world-class education in a world-renowned university is every scholar's dream but is often marred by the cost of living and exorbitant tuition fees.
Trudeau announces vaccine pact as Canada surpasses 150,000 Covid cases
Canadian Prime Minister Justin Trudeau on Friday announced that his government has entered into an agreement with British pharmaceutical giant AstraZeneca to procure 20 million doses of its coronavirus vaccine.
Oxford Covid vaccine trials delayed over safety approvals
New Delhi, Sep 6 The clinical trials for the Covid-19 vaccine candidate developed by the University of Oxford, ...
Don't chart separate vaccine procurement pathways, states urged
New Delhi, Aug 12 The National Expert Group on Vaccine Administration for Covid-19 met for the first time ...
Wockhardt wins UK govt deal on Covid-19 vaccine manufacturing
Mumbai, Aug 3 Mumbai-headquartered pharmaceutical company Wockhardt on Monday announced that it has entered into an agreement with ...
COVID-19 vaccine development: Only 3 vaccine candidate in phase III across world
In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and China, informed the official from the Union Health Ministry on Thursday.